[go: up one dir, main page]

NO20012616L - Middel til behandling av erektil malfunksjon - Google Patents

Middel til behandling av erektil malfunksjon

Info

Publication number
NO20012616L
NO20012616L NO20012616A NO20012616A NO20012616L NO 20012616 L NO20012616 L NO 20012616L NO 20012616 A NO20012616 A NO 20012616A NO 20012616 A NO20012616 A NO 20012616A NO 20012616 L NO20012616 L NO 20012616L
Authority
NO
Norway
Prior art keywords
erectile
malfunction
treatment
erectile malfunction
Prior art date
Application number
NO20012616A
Other languages
English (en)
Other versions
NO321797B1 (no
NO20012616D0 (no
Inventor
Keizo Tanikawa
Nobutomo Tsuruzoe
Norimasa Shudo
Toru Yamashita
Norihisa Ishiwata
Hideaki Kido
Hajime Ebisu
Kazutaka Hayashi
Yoshiji Kubo
Norifumi Nakamura
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of NO20012616D0 publication Critical patent/NO20012616D0/no
Publication of NO20012616L publication Critical patent/NO20012616L/no
Publication of NO321797B1 publication Critical patent/NO321797B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20012616A 1998-12-07 2001-05-29 Anvendelse av et 3(2H)-pyridazinonderivat for fremstilling av et terapeutisk preparat til behandling av erektil malfunksjon NO321797B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34679898 1998-12-07
PCT/JP1999/006693 WO2000033845A1 (en) 1998-12-07 1999-11-30 Remedial agent for erectile dysfunction

Publications (3)

Publication Number Publication Date
NO20012616D0 NO20012616D0 (no) 2001-05-29
NO20012616L true NO20012616L (no) 2001-08-07
NO321797B1 NO321797B1 (no) 2006-07-03

Family

ID=18385894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012616A NO321797B1 (no) 1998-12-07 2001-05-29 Anvendelse av et 3(2H)-pyridazinonderivat for fremstilling av et terapeutisk preparat til behandling av erektil malfunksjon

Country Status (15)

Country Link
EP (1) EP1157694A4 (no)
KR (1) KR100633869B1 (no)
CN (1) CN1163230C (no)
AU (1) AU768825B2 (no)
CA (1) CA2353956C (no)
CZ (1) CZ20012020A3 (no)
IL (2) IL143530A0 (no)
NO (1) NO321797B1 (no)
NZ (1) NZ512754A (no)
RU (1) RU2229885C2 (no)
SK (1) SK286984B6 (no)
TW (1) TW585767B (no)
UA (1) UA73104C2 (no)
WO (1) WO2000033845A1 (no)
ZA (1) ZA200105429B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2356555C2 (ru) * 2003-12-26 2009-05-27 Ниссан Кемикал Индастриз, ЛТД Антинейтрофильное средство
EP1714654A4 (en) * 2004-02-09 2011-02-16 Nissan Chemical Ind Ltd MEDICAMENT FOR INHIBITING VASCULAR INTIMATE HYPERPLASIA
RU2536425C2 (ru) * 2013-01-17 2014-12-20 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция, содержащая силденафил цитрат, и способ ее приготовления
JP6865933B2 (ja) 2018-02-23 2021-04-28 株式会社Ｍｅｉｓ Ｔｅｃｈｎｏｌｏｇｙ 勃起不全治療剤
CN113546049B (zh) * 2021-04-30 2023-03-17 贵州汉方药业有限公司 一种柔性丸剂药物黏合剂及使用该黏合剂制成的柔性丸剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978665A (en) * 1987-01-20 1990-12-18 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
AU634655B2 (en) * 1990-04-25 1993-02-25 Nissan Chemical Industries Ltd. Pyridazinone derivative
NZ270130A (en) * 1993-12-16 1995-12-21 Nihon Nohyaku Co Ltd Pyridazinone derivatives, preparation and pharmaceutical compositions thereof
ES2147841T3 (es) * 1994-01-25 2000-10-01 Nissan Chemical Ind Ltd Derivados de piridazinona.
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives
US6288064B1 (en) * 1996-08-20 2001-09-11 Eisai Co., Ltd. Remedy for erection failure comprising fused pyridazine compound
TW482675B (en) * 1997-01-31 2002-04-11 Green Cross Corp Compositions for oral administration containing pyridazinone compounds technical field of the invention
EP1025847B1 (en) * 1997-08-28 2005-10-26 Nissan Chemical Industries, Ltd. Neovascularization promoters and neovascularization potentiators
AU734734B2 (en) * 1997-10-28 2001-06-21 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
SK286984B6 (sk) 2009-08-06
KR20010081067A (ko) 2001-08-25
RU2229885C2 (ru) 2004-06-10
NO321797B1 (no) 2006-07-03
SK7062001A3 (en) 2001-11-06
AU1413100A (en) 2000-06-26
IL143530A (en) 2006-12-31
WO2000033845A1 (en) 2000-06-15
KR100633869B1 (ko) 2006-10-16
NO20012616D0 (no) 2001-05-29
NZ512754A (en) 2002-10-25
IL143530A0 (en) 2002-04-21
CN1329492A (zh) 2002-01-02
EP1157694A4 (en) 2002-08-28
CN1163230C (zh) 2004-08-25
CA2353956A1 (en) 2000-06-15
AU768825B2 (en) 2004-01-08
TW585767B (en) 2004-05-01
CZ20012020A3 (cs) 2001-10-17
EP1157694A1 (en) 2001-11-28
UA73104C2 (en) 2005-06-15
CA2353956C (en) 2008-10-28
ZA200105429B (en) 2002-07-02

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
NO20012160D0 (no) Anordning for behandling av makulös degenerering
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
NO20022087L (no) Fremgangsmåte for behandling av diabetes
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20005179D0 (no) Medikament behandling
NO20012106D0 (no) Middel for behandling av benpatobolisme
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20013146D0 (no) Middel for behandling av synscellefunksjonsforstyrrelser
NO20013596D0 (no) Slambehandling
NO20012616L (no) Middel til behandling av erektil malfunksjon
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
IS5481A (is) Samsett meðferð til meðhöndlunar á alnæmi
PT970080E (pt) Derivados de imino-aza-antraciclinona para o tartamento de amiloidoses
NO20022253D0 (no) Middel til behandling av hepatitt C

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees